Eris Lifesciences Limited has announced that Krishnakumar Vaidyanathan has tendered his resignation from the positions of Executive Director and Chief Operating Officer, with effect from the close of business hours on September 30, 2026, as he seeks professional opportunities outside the organization. The resignation has been accepted by the Chairman, and the company will relieve him from his duties at the end of September. In a note accompanying the announcement, Eris Lifesciences thanked Vaidyanathan for his leadership, contributions, and dedication during his tenure.
The leadership change comes as Eris Lifesciences continues to navigate a competitive landscape in the lifesciences space. While the company did not outline a detailed transition plan, it signaled a commitment to ensuring business continuity and an orderly handover as it progresses with its strategic initiatives. The progression of executive leadership is being managed with an eye toward maintaining momentum in operations and execution across the organization.
Eris Lifesciences emphasized its appreciation for Vaidyanathan’s service and the impact of his work during his tenure. The company noted that it will undertake a structured transition process to appoint a successor and to align on responsibilities, ensuring a seamless continuation of day-to-day operations and strategic priorities for the business.